Korean Circ J.  2011 Oct;41(10):575-577. 10.4070/kcj.2011.41.10.575.

Hypertension, Vascular Rarefaction and Angiopoietin-1

• Bae JW

• KMID: 2297915
• DOI: http://doi.org/10.4070/kcj.2011.41.10.575

Abstract

No abstract available.

MeSH Terms

Angiopoietin-1
Hypertension
Angiopoietin-1

Reference

1. Sane DC, Anton L, Brosnihan KB. Angiogenic growth factors and hypertension. Angiogenesis. 2004. 7:193–201.

2. Redon J. Antihypertensive treatment: should it be titrated to blood pressure reduction or to target organ damage regression? Curr Opin Nephrol Hypertens. 2005. 14:448–452.

3. Lee JS, Song SH, Kim JM, et al. Angiopoietin-1 prevents hypertension and target organ damage through its interaction with endothelial Tie2 receptor. Cardiovasc Res. 2008. 78:572–580.

4. Suh W, Lee JS, Kim KL, Song SH, Koh GY, Kim DK. Angiopoietin-1 gene therapy attenuates hypertension and target organ damage in nitric oxide synthase-inhibited spontaneously hypertensive rats. Korean Circ J. 2011. 41:590–595.

5. Koller A. Signaling pathways of mechanotransduction in arteriolar endothelium and smooth muscle cells in hypertension. Microcirculation. 2002. 9:277–294.

6. Rizzoni D, Rodella L, Porteri E, et al. Time course of apoptosis in small resistance arteries of spontaneously hypertensive rats. J Hypertens. 2000. 18:885–891.

7. Antonios TF, Rattary FM, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in normotensive off-spring of individuals with essential hypertension. Heart. 2003. 89:175–178.

8. Kim HZ, Jung K, Kim HM, Cheng Y, Koh GY. A designed angiopoietin-2 variant, pentameric COMP-Ang2, strongly activates Tie2 receptor and stimulates angiogenesis. Biochim Biophys Acta. 2009. 1793:772–780.

9. Brindle NP, Saharinen P, Alitalo K. Signaling and functions of angiopoietin-1 in vascular protection. Circ Res. 2006. 98:1014–1023.

10. Thurston G, Suri C, Smith K, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 1999. 286:2511–2514.